Conditionally Licensed Monoclonal Antibody + CCNU Chemotherapy for Dogs with T-Cell Lymphoma
NEVOG is currently enrolling cases in a nationwide clinical trial to evaluate a monoclonal antibody (AT-005) that is conditionally licensed by the USDA to aid in the treatment of dogs with lymphoma. The study is designed to assess the benefit of adding AT-005 to a single-agent CCNU chemotherapy protocol for dogs with intermediate to high grade T-cell lymphoma.
Funded Clinical Trial for Dogs with Oral Melanoma
Summary: New England Veterinary Oncology Group is currently offering enrollment in a randomized controlled study to determine the efficacy and safety of a gene transfer immunotherapy approach in combination with radiation therapy for the treatment of oral melanoma in dogs. AdV-tk is an adenovirus vector that delivers a gene to tumor cells which can kill tumor cells when combined with acyclovir. This approach may improve local control as well as create a systemic immune response against the melanoma.
2015 Office Hour Changes
At times it is necessary for us to make adjustments to our scheduled hours. When we need to make changes we will post them on our web site.
N.E.V.O.G. is now seeing patients in Cape Cod MA, South Shore region MA, Manchester NH and Newington, NH.
The New England Veterinary Oncology Group LLP (NEVOG) the only private, comprehensive, veterinary oncology care center in New England based in Waltham MA, sees patients in New Hampshire at the Southern New Hampshire Veterinary Referral Hospital in Manchester, NH and the Veterinary Emergency, Critical Care and Cancer Center of NH in Newington as well as Cape Cod at Cape Cod Veterinary Specialists and the south shore region at VCA South Shore.
Drs. Andy Abbo, Kim Cronin, Jeff Philibert, Erin Romansik, Kari Rosen, Michelle Silver and Sheri Siegel bring to the Cape Cod, South Shore, Manchester and Newington offices the same high quality and compassionate care for which NEVOG is known.
Palladia, the new drug from Pfizer.
There has been much buzz and excitement surrounding FDA approval of Palladia (Pfizer), which is new drug licensed for treatment of mast cell tumors in dogs. Palladia is in the family of drugs called tyrosine kinase inhibitors which have been used in the treatment of cancer in humans for many years. Not only does Palladia provide veterinarians with a novel way to treat some of the more difficult mast cell tumors, it represents a commitment from drug companies like Pfizer to developing therapies specific for our veterinary cancer patients. Palladia is currently available only through veterinary oncologists and other selected specialists.
Emergency on call for active patients
NEVOG is pleased to offer an on-call after hours emergency service. The goal of this service is to help make recommendations in emergency situations. A NEVOG clinician will be available by phone to offer advice and if needed, direct you to the appropriate emergency facility. We will also be able to consult with an emergency clinician if it is recommended that your pet be seen.
Pet Friendly Hotels
We are often asked if there are pet friendly hotels in the area. While we do know of some hotels that are designated as pet friendly our list is not 100% comprehensive.